Elsubrutinib and its Impurities

Elsubrutinib, also known as ABBV-105, is an investigational, orally administered, potent, selective, and irreversible Bruton's tyrosine kinase inhibitor. Reference standards of Elsubrutinib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.